This trial tests the safety and effectiveness of an insulin pump and glucose monitor for adults and kids with type 1 diabetes.
- Type 1 Diabetes
4 Primary · 4 Secondary · Reporting Duration: 3 months
Side Effects for
2 Treatment Groups
1 of 2
MiniMed™ 780G system with DS5
1 of 2
250 Total Participants · 2 Treatment Groups
Primary Treatment: Arm 1 · No Placebo Group · N/A
Who is running the clinical trial?
Age 7 - 80 · All Participants · 13 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Do octogenarians qualify for participation in this research project?
"According to the trial's guidelines, those between 7 and 80 years old are suitable for enrollment." - Anonymous Online Contributor
Are participants currently being enlisted for this experiment?
"Evidently, this clinical trial is not presently enrolling new participants. The experiment was initially posted on March 1st 2023 and had its last update around the 26th of January in the same year. Although no longer accepting applicants, there are 370 other studies that need patients right now." - Anonymous Online Contributor
How many sites are facilitating the implementation of this clinical trial?
"This investigation is currently recruiting from 20 different sites, ranging from Palo Alto to Walnut Creek and beyond. Prospective participants should select the nearest location to minimize travel requirements if they decide to join this trial." - Anonymous Online Contributor
What conclusions is this research attempting to reach?
"This clinical trial is evaluating the safety of a new medication and will primarily assess HbA1c levels over three months. Additionally, it aims to evaluate the drug's efficacy by gauging the percent of time in hypoglycemia (Age 7-17) or range (TIR 70-180 mg/dL - Age 18-80 & 7-17) with noninferiority and superiority tests." - Anonymous Online Contributor
Are there any eligibility criteria for participation in this trial?
"This clinical trial is seeking 250 individuals suffering from type 1 diabetes, aged between seven and eighty. Candidates must meet the following criteria: be within the aforementioned age range at time of screening; have a diagnosis that can be verified by medical records or source documentation made by an accredited professional; not require legal representation to provide consent due to mental handicap; demonstrate literacy as well as comprehension in the language used for pump instructions; provide informed consent before enrolling in the study; execute fingerstick blood glucose measurements when needed; wear system continuously during duration of study period; possess minimum daily insulin requirement (Total Daily Dose) greater than 8 units of" - Anonymous Online Contributor